Vaping cannabis tied to more lung damage symptoms than cigarettes, nicotine

Organisation: Position: Deadline Date: Location:

Adolescents who vape cannabis are at greater risk of respiratory symptoms indicative of lung injury than teens who smoke cigarettes or marijuana, or vape nicotine, suggests a new University of Michigan study published in the Journal of Adolescent Health.

The result challenges conventional wisdom about vaping nicotine, said the study’s principal investigator, Carol Boyd, the Deborah J Oakley Collegiate Professor Emerita at the School of Nursing, wrote Laura Baily for Michigan News this week.

“I thought that e-cigarettes (vaping nicotine) would be the nicotine product most strongly associated with worrisome respiratory symptoms,” she said. “Our data challenges the assumption that smoking cigarettes or vaping nicotine is the most harmful to the lungs.

“If we control for vaping cannabis in our analyses, we find there is a weaker relationship between e-cigarette or cigarette use and respiratory symptoms when compared to vaping cannabis.”

Boyd, who also co-directs the university’s Center for Drugs, Alcohol, Smoking and Health, stressed that the findings do not mean that vaping nicotine or smoking cigarettes or marijuana are not bad for you. These products also produce symptoms of lung injury but not to the same degree as vaping marijuana, she said.

“In short, it is all bad but if you also vape cannabis you have a greater number of unhealthy respiratory symptoms than if you just smoke cigarettes or marijuana, or vape e-cigarettes,” Boyd said. “Without a doubt, cigarettes and e-cigarettes are unhealthy and not good for lungs. However, vaping marijuana appears even worse.”

Boyd and colleague Philip Veliz, research assistant professor of nursing, wanted to explore the association of unhealthy respiratory symptoms among US adolescents currently using cigarettes, e-cigarettes or cannabis and who had vaped cannabis within their lifetime.

Adolescents who reported vaping marijuana were roughly twice as likely to report “wheezing and whistling” in the chest than those who did not. Current use of cigarettes, e-cigarettes and cannabis were associated with some respiratory symptoms, such as dry cough, but most associations were not significant after controlling for vaping cannabis.

The researchers also found that an asthma diagnosis was most strongly associated with symptoms of future lung injury than cigarettes, e-cigarettes, cannabis use and vaping cannabis.

One study limitation is that the researchers did not look at co-use of vaping cannabis and the use of cigarettes or e-cigarettes.

“Future studies need to assess if it is the combination of vaping both nicotine and cannabis that is creating so many respiratory issues,” Veliz said. “It may be the combination of vaping cannabis along with smoking cigarettes is what leads to the high rates of respiratory symptoms among youthful marijuana vapers.”

Boyd and Veliz looked at self-reported symptoms from a sample of adolescents ages 12-17 years, from the 2016-2018 Wave of the Population Assessment of Tobacco and Health Study. Symptoms included wheezing and whistling in the chest, sleep disturbed or speech limited due to wheezing, sounded wheezy during or after exercise, and dry cough at night not associated with chest illness or infection.

 

Study details

Cannabis, Vaping, and Respiratory Symptoms in a Probability Sample of US Youth

Carol J Boyd, Sean Esteban McCabe, Rebecca J Evans and Philip T Veliz

Published in the Journal of Adolescent Health on 3 March 2021.

 

Abstract

The purpose of this study was to explore the association between respiratory symptoms among U.S. adolescents who were current (past 30-day) users of cigarettes, e-cigarettes, and/or cannabis, as well as lifetime users of cannabis with electronic nicotine delivery systems (ENDS).

Methods

Wave 4 from a national probability sample (N = 14,798) of adolescents (12–17 years) using Population Assessment of Tobacco and Health Study data was used for this study. Retention rate was 88.4%.

Results

The odds of indicating “wheezing or whistling” in the chest were roughly two times higher among those who had used cannabis in ENDS (adjusted odds ratio 1.81, 95% confidence interval 1.47–2.22); neither e-cigarettes nor cigarettes had a significant association with all five respiratory symptoms in the fully adjusted models.

Conclusions

This study provides preliminary evidence that adolescents' cannabis use with ENDS may have negative health consequences. Lifetime cannabis use with ENDS was substantially associated with higher odds of respiratory symptoms.

 

Michigan News story – Vaping cannabis tied to more lung damage symptoms (Open access)

 

Journal of Adolescent Health article – Cannabis, Vaping, and Respiratory Symptoms in a Probability Sample of US Youth (Restricted access)

 

SEE ALSO FROM MEDICALBRIEF’S ARCHIVES

 

Cannabis legalisation a ‘significant concern’ – American Heart Association

 

We should not allow a cannabis free-for-all – Yale ethicist

 

Frequent adolescent cannabis use linked to IQ decline – Irish Royal College

 

 

 

 


Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.